// App-Quantinova.ai

PB2157 : Fondaparinux versus Enoxaparin in the Treatment of Venous Thromboembolism in Cancer Patients: Retrospective Cohort Study – “ONCOTEV”

Researchers

Presenter

  • B. Abbate

Principal Investigators

  • A. Dalla Salda

  • E. Spaggiari

  • L. Depietri

  • M. Iotti

  • I. Lambertini

  • S. Corradini

  • M.R. Veropalumbo

  • A. Ghirarduzzi

Medical Centers

  • AUSL di Reggio Emilia - Arcispedale Santa Maria Nuova, IRCCS, Angiology and Cardiovascular Medicine Unit - Internal Medicine Department, Reggio Emilia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Enoxaparin

  • Enoxaparin sodium

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved